featured
Early Treatment With Tocilizumab and Mortality in COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
JAMA Intern Med 2020 Oct 20;[EPub Ahead of Print], S Gupta, W Wang, SS Hayek, L Chan, KS Mathews, ML Melamed, SK Brenner, A Leonberg-Yoo, EJ Schenck, J Radbel, J Reiser, A Bansal, A Srivastava, Y Zhou, D Finkel, A Green, M Mallappallil, AJ Faugno, J Zhang, JCQ Velez, S Shaefi, CR Parikh, DM Charytan, AM Athavale, AN Friedman, RE Redfern, SAP Short, S Correa, KK Pokharel, AJ Admon, JP Donnelly, HB Gershengorn, DJ Douin, MW Semler, MA Hernán, DE Leaf, STOP-COVID InvestigatorsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.